CINETIQUE Translations
Cinetique Translations began as a one-woman operation in 2002 in Manchester (UK) when Laurence Auffret, a lecturer in translation at the University of Manchester and a qualified biologist, decided to combine her two areas of expertise: languages and life sciences. With an initial focus on the European market, the company’s first lines of business included training, management and language services for a variety of clients, including conducting training programmes for science students participating in Erasmus exchange programmes, acting as public relations manager for a number of international artists, managing cultural programmes and preparing Material Safety Data Sheets and labels for laboratory materials used in the French medical industry.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Atlas Translations Ltd
With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Company Details
Latest Content from PMHub
Climbing my own Lucid Ladder
Press Releases | December 7, 2021 | Lucid Group Communications Limited
Transforming lives. That’s what Lucid is all about. I knew that even before I stepped through the fabled door of ‘Towers’ on a chilly January morning in 2019. It’s why...
A Lucid Thirsty Thursday D&I Special
Press Releases | December 3, 2021 | Lucid Group Communications Limited
Last week’s ‘Thirsty Thursday’ session was organised by the Lucid Group D&I Committee, whose goal is to foster a culture where diversity and inclusivity are embedded and practised within all...
Diversity in clinical trials: looking back at our 2021 blogs
White Papers and Resources | December 3, 2021 | Innovative Trials
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021
Gamifying Surgical Training to Improve Patient Outcomes
Videos and Podcasts | December 2, 2021 | Impetus Digital
Dr. Justin Barad, CEO and Founder of Osso VR, explores how VR and gamification are revolutionizing surgical training by providing accurate quantitative assessments and analytics before performing on a patient....
Connecting capabilities in healthcare communications
Press Releases | December 2, 2021 | Lucid Group Communications Limited
The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated,...
Connecting capabilities in healthcare communications
Videos and Podcasts | December 2, 2021 | Lucid Group Communications Limited
The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated,...
What does the future hold for Light-chain Amyloidosis?
White Papers and Resources | December 1, 2021 | Inizio
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Onyx Health Announces Two Top Appointments
Press Releases | November 30, 2021 | Onyx Health
Onyx health have made two senior appointments to their communications team
Lucid Group: Orange the World
Press Releases | November 26, 2021 | Lucid Group Communications Limited
Yesterday was International Day For The Elimination Of Violence Against Women. It marked the launch of the UNiTE to end the violence against women campaign, which runs for 16 days...
From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
Videos and Podcasts | November 25, 2021 | Impetus Digital
Joshua Yang, Co-founder & CEO of Glyphic Biotechnologies and Co-founder of NephroSant, dives into next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and...